Dow Down0.96% Nasdaq Down1.15%

Tekmira Pharmaceuticals Corp (TKMR)

-NasdaqCM
24.96 Up 3.82(18.07%) 10:46AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 15,464   14,105   16,812  
Cost of Revenue -   -   -  
Gross Profit 15,464   14,105   16,812  
Operating Expenses
Research Development21,458  18,043  20,132  
Selling General and Administrative5,546  8,141  6,386  
Non Recurring -   -   -  
Others613  866  987  
Total Operating Expenses -   -   -  
Operating Income or Loss (12,153) (12,945) (10,694)
Income from Continuing Operations
Total Other Income/Expenses Net(1,911)42,557  610  
Earnings Before Interest And Taxes(14,064)29,612  (10,083)
Interest Expense -   -   -  
Income Before Tax(14,064)29,612  (10,083)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(14,064)29,612  (10,083)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (14,064) 29,612   (10,083)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (14,064) 29,612   (10,083)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.